Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Sells 1,000 HumanHap550 BeadChips to Glaxo

NEW YORK (GenomeWeb News) — Illumina has sold 1,000 of its HumanHap550 BeadChips to GlaxoSmithKline, Illumina said today.
 
Under the agreement, GSK will use Illumina’s services and hardware at a “third party facility” in what Illumina said is a continuation and expansion of an existing genotyping arrangements between the two companies.
 
The firms have had running genotyping agreements for more than five years.
 
Financial terms of the agreement were not disclosed.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.